天邦股份(002124.SZ)漲4% 豬價超預期 三季度扭虧為盈
格隆匯10月18日丨天邦股份(002124.SZ)漲4%,報13.07元,暫成交8.31億元,最新總市值152億元。天邦股份昨晚公佈業績顯示,前三季度實現淨利潤1194萬元,同比下降90.12%,但第三季度實現淨利潤3793萬元,同比增長841.90%。據公司披露,公司生豬養殖業務Q1虧損2.96億元,Q2虧損6600萬元,隨着三季度豬價走高以及生物安全防控措施的提升,公司生豬業務盈利水平大幅提升,Q3養豬業務實現淨利潤約2億元。東北證券上調其評級為買入,6個月目標價為27.4元,相較於現價潛在升幅高為110%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.